[85]
In providing his opinion that the Novopharm product monograph could not contain anything different from the corresponding PREVACID product monograph, Dr. Liston was careful to exclude information concerning bioequivalence and non-medicinal ingredients. At paragraph 28 of his affidavit, he stated as follows:
"
Apart from the comparative bioequivalence, however presented, and list of non-medicinal ingredients
, Novopharm's Product Monograph cannot contain any substantive information that differs from the corresponding information in the PREVACID(r) Product Monograph ..." (Emphasis added)